IGM Biosciences Inc (IGMS)
9.465
-0.14
(-1.51%)
USD |
NASDAQ |
May 01, 16:00
9.465
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Price: 9.465 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 9.50 | 9.86 | 9.150 | 9.61 | 214269.0 |
Apr 29, 2024 | 9.46 | 10.47 | 9.38 | 9.70 | 599162.0 |
Apr 26, 2024 | 7.74 | 9.48 | 7.41 | 9.40 | 468943.0 |
Apr 25, 2024 | 7.76 | 7.76 | 6.39 | 7.65 | 546460.0 |
Apr 24, 2024 | 7.76 | 8.66 | 7.75 | 7.96 | 693446.0 |
Apr 23, 2024 | 6.79 | 7.85 | 6.79 | 7.70 | 413520.0 |
Apr 22, 2024 | 7.25 | 7.25 | 6.70 | 6.75 | 238720.0 |
Apr 19, 2024 | 7.35 | 7.43 | 7.04 | 7.20 | 219365.0 |
Apr 18, 2024 | 8.01 | 8.266 | 7.12 | 7.41 | 446866.0 |
Apr 17, 2024 | 9.37 | 9.37 | 8.050 | 8.13 | 252208.0 |
Apr 16, 2024 | 9.18 | 9.56 | 8.99 | 9.20 | 140343.0 |
Apr 15, 2024 | 9.14 | 9.79 | 8.93 | 9.41 | 185549.0 |
Apr 12, 2024 | 8.32 | 9.30 | 8.283 | 9.16 | 321381.0 |
Apr 11, 2024 | 8.27 | 8.41 | 8.09 | 8.36 | 232692.0 |
Apr 10, 2024 | 8.74 | 8.74 | 7.93 | 8.18 | 238041.0 |
Apr 09, 2024 | 8.81 | 9.07 | 8.64 | 8.74 | 170556.0 |
Apr 08, 2024 | 8.86 | 9.14 | 8.605 | 8.76 | 125594.0 |
Apr 05, 2024 | 8.75 | 9.11 | 8.59 | 8.76 | 98674.00 |
Apr 04, 2024 | 9.21 | 9.52 | 8.86 | 8.89 | 126699.0 |
Apr 03, 2024 | 9.33 | 9.33 | 8.66 | 9.03 | 138812.0 |
Apr 02, 2024 | 9.27 | 9.36 | 8.95 | 9.14 | 142102.0 |
Apr 01, 2024 | 10.47 | 10.85 | 9.31 | 9.45 | 270688.0 |
Mar 28, 2024 | 9.28 | 9.71 | 9.201 | 9.65 | 244280.0 |
Mar 27, 2024 | 8.79 | 9.41 | 8.65 | 9.27 | 264843.0 |
Mar 26, 2024 | 8.78 | 9.092 | 8.21 | 8.68 | 592532.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.94
Minimum
Oct 31 2023
121.23
Maximum
Feb 09 2021
37.41
Average
23.00
Median
Feb 17 2023
Price Benchmarks
Inotiv Inc | 3.93 |
Synlogic Inc | 1.83 |
BioXcel Therapeutics Inc | 2.55 |
Xilio Therapeutics Inc | 1.10 |
NovaBay Pharmaceuticals Inc | 0.0892 |
Price Related Metrics
PS Ratio | 232.27 |
Price to Book Value | 2.738 |
Earnings Yield | -50.50% |
Market Cap | 556.42M |